XT

joimax® Experiences Major Growth, Launches TESSYS® TransSAP Endoscopic Surgical System

Retrieved on: 
火曜日, 10月 18, 2022
General Health, Health, Surgery, Medical Devices, Method, Titanium, XT, Disease, Growth, Stenosis, Superior, Spinal canal, NASS, Multimedia, Technology, University, DWG, Spine, Neurology, Department, CEO, View, CNS, Animal testing at the University of Washington, Sacroiliac joint pain, Surgeon, Medical device, Aquaculture

Over the past 9 months, joimax has grown more than 25% globally and in the United States alone, more than 35%.

Key Points: 
  • Over the past 9 months, joimax has grown more than 25% globally and in the United States alone, more than 35%.
  • Among this major spurt, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery is launching a new endoscopic surgical system, TESSYS TransSAP.
  • To keep momentum, joimax is releasing the TESSYS TransSAP the fourth addition to the TESSYS family encompassing the standard TESSYS Std, TESSYS XT featuring longer reach instruments, and TESSYS Thx, the optimized version for the thoracic spine.
  • All joimax implants can be safely inserted using the Over-the-Wire technique for precise implantation, making them ideal for endoscopically-assisted fusion procedures established and protected by joimax.

MOFT Listed On XT.COM With Tether Trading Pair

Retrieved on: 
水曜日, 10月 19, 2022
Mobius, Adoption, Decentralized finance, NFT, XT, Social, Ecosystem, Cryptocurrency, Mobile phone

SINGAPORE, Oct. 19, 2022 /PRNewswire/ -- XT.COM, the world's first socially infused trading platform, is pleased to announce the latest listing of MOFT token (Mobius Strip Finance).

Key Points: 
  • SINGAPORE, Oct. 19, 2022 /PRNewswire/ -- XT.COM, the world's first socially infused trading platform, is pleased to announce the latest listing of MOFT token (Mobius Strip Finance).
  • Users can effortlessly trade MOFT tokens on the XT trading platform.
  • Mobius Strip Finance's utility token, MOFT, is deployed on Binance Smart chain as a BEP-20 token.
  • By consistently expanding its ecosystem, XT.COM is dedicated to providing users with the most secure, trusted, and hassle-free digital asset trading services.

XT.COM Listed LAT on its Innovation Zone

Retrieved on: 
火曜日, 10月 18, 2022
USDT, Developer, Privacy, XT, LAT, Platon, Connected Data Objects, AGI, Algorithm, Cryptocurrency, AI

SINGAPORE, Oct. 18, 2022 /PRNewswire/ --XT.COM, the world's first socially infused trading platform, is pleased to announce the listing of the LAT token in its Innovation Zone.

Key Points: 
  • SINGAPORE, Oct. 18, 2022 /PRNewswire/ --XT.COM, the world's first socially infused trading platform, is pleased to announce the listing of the LAT token in its Innovation Zone.
  • The token is listed with USDT pairing, and users can buy, sell and trade LAT tokens seamlessly on XT.COM.
  • LAT is the native utility token which captures the value of trustless coordination between actors within the PlatON network.
  • LAT holders may also delegate their LAT to the validator and get a certain reward share.

XT.COM has Listed XTC (X Technology) In Its Main Zone (DeFi)

Retrieved on: 
火曜日, 10月 18, 2022
XTC, XT, NFT, Technology, Social, Ecosystem, Cryptocurrency

The XTC token can be sold, bought, traded and staked on the XT platform to make it beneficial for several utilities including earning of cashbacks, or even paying the gas fee for transactions.

Key Points: 
  • The XTC token can be sold, bought, traded and staked on the XT platform to make it beneficial for several utilities including earning of cashbacks, or even paying the gas fee for transactions.
  • XT offers its users this XTC token that can be used to drive all transactions and payments on the real currency exchange.
  • This also gives the privilege for XTC to reach out to a wider audience by having it listed on a global platform like XT.COM.
  • Furthermore, to ensure optimal data integrity and security, we see user security as our top priority at XT.COM.

UVCT Gets Listed On XT.COM In The Main Zone (DeFi)

Retrieved on: 
火曜日, 10月 18, 2022
Universe, Insurance, P2P, XT, NETWORK, BNB, Social, NFT, LP, DAO, Acquisition, Blockchain, Ecosystem, Decentralized finance, Internet, UTC, Cryptocurrency, DAPP

SINGAPORE, Oct. 17, 2022 /PRNewswire/ -- XT.COM, the world's first social infused exchange, is thrilled to announce the listing of the UVCT token on the platform in the Main Zone (DeFi).

Key Points: 
  • SINGAPORE, Oct. 17, 2022 /PRNewswire/ -- XT.COM, the world's first social infused exchange, is thrilled to announce the listing of the UVCT token on the platform in the Main Zone (DeFi).
  • The UVCT token will be a valuable addition to the XT platform as it aims at solving problems within the DeFi sector.
  • The Universe chain token is a bep-20 token deployed on the Binance Smart Chain network and the native asset of the UVCT Network, a decentralized finance application.
  • UVCT NETWORK employs 3 simple functions: Reflection, LP acquisition, and token Burning for each trade that takes place.

XT.COM Lists ASTA On Its Platform In Innovation Zone

Retrieved on: 
月曜日, 10月 17, 2022
Ethereum, USDT, Marketing, XT, NFT, BSC, Efficiency, Social, ASTA, Ecosystem, Cryptocurrency

SINGAPORE, Oct. 14, 2022 /PRNewswire/ -- XT.COM, a leading global trading platform and the world's first socially infused trading platform, is thrilled to announce that ASTA is being listed in the Innovation Zone of the platform.

Key Points: 
  • SINGAPORE, Oct. 14, 2022 /PRNewswire/ -- XT.COM, a leading global trading platform and the world's first socially infused trading platform, is thrilled to announce that ASTA is being listed in the Innovation Zone of the platform.
  • By having ASTA listed on the platform, XT.COM aims to support the users in various daily life activities as the token can be used for several real-life utilities.
  • The token belongs to a future-ready virtual payment platform that can be used in real life for various purposes.
  • ASTA is a virtual asset-based payment platform devised to circumvent the various challenges associated with virtual assets.

Bizverse (BIVE) - Metaverse project joining "Meta Start up Accelerator and IMDA" - Gets Listed On XT.COM In Main Zone

Retrieved on: 
木曜日, 10月 13, 2022
XT, BNB, Virtual reality, Meta, Attention, 3D, Business, Blockchain, Ecosystem, Stater, Advertising, VR, UTC, Digital twin, Private, Cryptocurrency, Metaverse

This, in turn, makes it beneficial for both the XT community as well the BIVE users.

Key Points: 
  • This, in turn, makes it beneficial for both the XT community as well the BIVE users.
  • While the users of XT can trade better with newer tokens being listed, the BIVE community can trade on a global platform with a huge audience.
  • BIVE IDO Sold Out in 20 Seconds on XT Stater is the sign for a great journey for Bizverse on XT.
  • The project has now reached 300,000 active users on Bizverse Social, 200,000,000+ posts and 28,000,000+ comments on social platforms.

MFET Gets Listed on XT.COM Main Zone With USDT Pairing

Retrieved on: 
水曜日, 10月 12, 2022
Biodiversity, Environment, Climate change, XT, Carbon, Stake (Latter Day Saints), Carbon footprint, Efficiency, Ecosystem, Awareness, Greenhouse, Cryptocurrency

SINGAPORE, Oct. 12, 2022 /PRNewswire/ -- XT.COM, one of the leading global trading exchanges and the world's first socially infused trading platform, is thrilled to announce that MFET is being listed in the Main Zone of the platform.

Key Points: 
  • SINGAPORE, Oct. 12, 2022 /PRNewswire/ -- XT.COM, one of the leading global trading exchanges and the world's first socially infused trading platform, is thrilled to announce that MFET is being listed in the Main Zone of the platform.
  • With this collaboration, the XT community would get an exposure to high-profile tokens like MFET, and this also helps in taking the MFET token to a wide user base of XT.COM.
  • As a green token based on the environment, biodiversity and sustainable economy, MFET make every action contribute to nature.
  • MFET is listed in the main zone, providing traders with exciting projects to trade with.

Atlis Motor Vehicles Expands Agreement with AUSEV to Include Distribution of 1.5MW Charging Stations, XP Platforms, and Battery Packs in Australia; Parties to Explore Battery Cell Production Partnership

Retrieved on: 
火曜日, 10月 11, 2022
Adoption, Internal combustion engine, XT, Sale, Motor vehicle, Technology, Recreational vehicle, EVS, ICE, Company, RHD, EV, ATLIS II, CEO, Garbage, GLOBE, Forward-looking statement, Audit

The parties intend to explore the potential for local battery cell production in Australia.

Key Points: 
  • The parties intend to explore the potential for local battery cell production in Australia.
  • These two foundational orders from AUSEV demonstrate our commitment to scaling up production and AUSEVs growing faith in Atlis.
  • We are grateful for our continued collaboration with AUSEV and expect to extend the AUSEV collaborative and distribution model to other territories.
  • Atlis Motor Vehicles Inc. is a vertically integrated electric vehicle company committed to electrifying work vehicles.

Tempus Announces Companion Diagnostic Collaboration with Kartos Therapeutics

Retrieved on: 
木曜日, 10月 6, 2022
Technology, Clinical Trials, Health Technology, Biotechnology, Other Health, Health, Pharmaceutical, Data Management, Artificial Intelligence, Physician, LinkedIn, Tumor suppressor gene, Risk, Therapy, Neoplasm, Phase II, Merkel-cell carcinoma, TP53, XT, MDM2, Intelligence, Patient, Library, Twitter, Cdx, Metastasis, Partnership, Precision medicine, Cancer, Solution, MCC, MD, Health, Immunotherapy, Recurrence, Karto-Zan languages, Apoptosis, Skin cancer, Pharmaceutical industry, Tempus

Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical stage biopharmaceutical company, in support of its ongoing Phase II study of navtemadlin (KRT-232) .

Key Points: 
  • Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical stage biopharmaceutical company, in support of its ongoing Phase II study of navtemadlin (KRT-232) .
  • Tempus CDx test, which will be developed on Tempus xT platform, will be used to identify patients with TP53 wild-type (TP53WT) Merkel cell carcinoma (MCC) who may be eligible for treatment with navtemadlin.
  • We are pleased to be collaborating with the Tempus team to progress our goal of developing innovative therapies that meaningfully improve the lives of patients, said Jesse McGreivy, MD, Chief Executive Officer and Chief Medical Officer at Kartos Therapeutics.
  • We look forward to supporting Kartos diagnostic efforts in identifying cancer patients who could benefit from a more personalized approach to their treatment using a widely-available assay and clinician-friendly tools.